CpG island promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2

Oncogene

Volumn 25, Issue 33, 2006, Pages 4559-4572

  Pulukuri, S M ^a   Rao, J S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

14 3 3 ; CpG methylation; MBD2; Prostate cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CELL NUCLEUS ANTIGEN; DNA; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; PROLIFERATION CELL NUCLEAR ANTIGEN; PROTEIN 14 3 3; PROTEIN 14 3 3SIGMA; SMALL INTERFERING RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

14 3 3ALPHA GENE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN LNCAP; CELL STRAIN TRAMP C1; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC DISORDER; HUMAN; HUMAN CELL; KNOCKOUT GENE; MALIGNANT TRANSFORMATION; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILENCER ELEMENT; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; EXONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR MARKERS, BIOLOGICAL;

EID: 33746798450     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209462     Document Type: Article

References (57)

1. Baylin SB, Herman JG. (2000). Trends Genet 16: 168-174.
2. Bird A. (2002). Genes Dev 16: 6-21.
3. Bird AP, Wolffe AP. (1999). Cell 99: 451-454.
4. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. (1999). Nature 401: 616-620.
5. Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L et al. (2004). Clin Cancer Res 10: 3064-3068.
6. Darwanto A, Kitazawa R, Maeda S, Kitazawa S. (2003). Cancer Sci 94: 442-447.
7. De Smet C, Loriot A, Boon T. (2004). Mol Cell Biol 24: 4781-4790.
8. Dougherty MK, Morrison DK. (2004). J Cell Sci 117: 1875-1884.
9. Ego T, Tanaka Y, Shimotohno K. (2005). Oncogene 24: 1914-1923.
10. Esteller M. (2005). Annu Rev Pharmacol Toxicol 45: 629-656.
11. Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA et al. (2001). Cancer Res 61: 4689-4692.
12. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H et al. (2000). Proc Natl Acad Sci USA 97: 6049-6054.
13. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G et al. (2005). Nat Genet 37: 391-400.
14. Frommer M, McDonald LE, Millar DS, CollisCM, Watt F, Grigg GW et al. (1992). Proc Natl Acad Sci USA 89: 1827-1831.
15. Fu H, Subramanian RR, Masters SC. (2000). Annu Rev Pharmacol Toxicol 40: 617-647.
16. Fujita N, Takebayashi S, Okumura K, Kudo S, Chiba T, Saya H et al. (1999). Mol Cell Biol 19: 6415-6426.
17. Galm O, Suzuki H, Akiyama Y, Esteller M, Brock MV, Osieka R et al. (2005). Oncogene 24: 4799-4805.
18. Goodman PA, Burkhardt N, Juran B, TibblesHE, Uckun FM. (2003). Oncogene 22: 2504-2514.
19. Hermeking H. (2003). Nat Rev Cancer 3: 931-943.
20. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T et al. (2000). Oncogene 19: 5298-5302.
21. Jenuwein T, AllisCD. (2001). Science 293: 1074-1080.
22. Jones PA. (1999). Trends Genet 15: 34-37.
23. Jones PA, Baylin SB. (2002). Nat Rev Genet 3: 415-428.
24. Jones PA, Laird PW. (1999). Nat Genet 21: 163-167.
25. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y et al. (2004). Biochem Biophys Res Commun 316: 1156-1162.
26. Kitazawa S, Kitazawa R, Maeda S. (1999). J Biol Chem 274: 28787-28793.
27. Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M et al. (2003). Oncogene 22: 4509-4516.
28. Lin X, Nelson WG. (2003). Cancer Res 63: 498-504.
29. Lodygin D, Diebold J, Hermeking H. (2004). Oncogene 23: 9034-9041.
30. Lodygin D, Hermeking H. (2005). Cell Res 15: 237-246.
31. Lodygin D, Yazdi AS, Sander CA, Herzinger T, Hermeking H. (2003). Oncogene 22: 5519-5524.
32. McKie AB, Douglas DA, Olijslagers S, Graham J, Omar MM, Heer R et al. (2005). Oncogene 24: 2166-2174.
33. Mhawech P. (2005). Cell Res 15: 228-236.
34. Mhawech P, Benz A, Cerato C, Greloz V, Assaly M, Desmond JC et al. (2005). Mod Pathol 18: 340-348.
35. Muslin AJ, Xing H. (2000). Cell Signal 12: 703-709.
36. Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y et al. (2003). Oncogene 22: 8835-8844.
37. Nguyen CT, Gonzales FA, Jones PA. (2001). Nucleic Acids Res 29: 4598-4606.
38. Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T et al. (2002). Oncogene 21: 2418-2424.
39. Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA. (2004). J Biol Chem 279: 31735-31744.
40. Pakneshan P, Xing RH, Rabbani SA. (2003). FASEB J 17: 1081-1088.
41. Park J, Song SH, Kim TY, Choi MC, Jong HS, Kim TY et al. (2004). Oncogene 23: 3474-3480.
42. Patra SK, Patra A, Zhao H, Carroll P, Dahiya R. (2003). Biochem Biophys Res Commun 302: 759-766.
43. Reichelt J, Magin TM. (2002). J Cell Sci 115: 2639-2650.
44. Santini V, Kantarjian HM, Issa JP. (2001). Ann Intern Med 134: 573-586.
45. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE. (2005). Mol Endocrinol 19: 1740-1751.
46. Singal R, Ginder GD. (1999). Blood 93: 4059-4070.
47. Singal R, van Wert J, Bashambu M. (2001). Cancer Res 61: 4820-4826.
48. Stirzaker C, Song JZ, Davidson B, Clark SJ. (2004). Cancer Res 64: 3871-3877.
49. Tanaka K, Hatada T, Kobayashi M, Mohri Y, Tonouchi H, Miki C et al. (2004). Int J Oncol 25: 1591-1597.
50. Tate PH, Bird AP. (1993). Curr Opin Genet Dev 3: 226-231.
51. Tzivion G, Avruch J. (2002). J Biol Chem 277: 3061-3064.
52. Tzivion G, Shen YH, Zhu J. (2001). Oncogene 20: 6331-6338.
53. Urano T, Takahashi S, Suzuki T, Fujimura T, Fujita M, Kumagai J et al. (2004). Biochem Biophys Res Commun 319: 795-800.
54. Woodcock JM, Murphy J, Stomski FC, Berndt MC, Lopez AF. (2003). J Biol Chem 278: 36323-36327.
55. Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T. (2002). Oncogene 21: 8310-8319.
56. Yu F, Thiesen J, Stratling WH. (2000). Nucleic Acids Res 28: 2201-2206.
57. Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D. (2004). J Biol Chem 279: 34353-34360.